The FDA currently has approved three forms of semaglutide: Ozempic , for treating type 2 diabetes Rybelsus , for the treatment of type 2 diabetes Wegovy , for chronic weight management Novo Nordisk manufactures all three forms of the drug
In general, tirzepatide tends to produce greater weight loss at comparable escalation stages, though it uses a different dosing scale (starting at 2.5 mg and escalating to 15 mg)
In men, obesity, diabetes and metabolic syndrome (a cluster of conditions that increase the risk of heart disease and stroke) have negative effects on fertility
By Francesca Alfano, MS, CDN, CNS, IFNCP Protein Intake on GLP-1 Medications: How Much You Need and How to Get Enough GLP-1 medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are increasingly used for weight loss and blood sugar management
The donation process removes approximately 600-800 mL of plasma (per FDA regulations in 21 CFR 640.65), which can temporarily affect fluid balance, blood pressure, and metabolic homeostasisfactors particularly relevant for patients managing diabetes or undergoing active weight loss
People who are pregnant or breastfeeding, who have active cancer, or who have certain medical conditions should generally avoid it unless a qualified clinician advises otherwise
